Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:28 PM
Ignite Modification Date:
2025-12-24 @ 2:28 PM
NCT ID:
NCT01141959
Eligibility Criteria:
Inclusion Criteria:
* Scheduled to receive nonmyeloablative conditioning which includes fludarabine
* Scheduled to receive a haploidentical graft
* Scheduled to receive postgrafting immunosuppression which includes oral mycophenolate mofetil (MMF) or enteric-coated mycophenolic acid
* Age \>18 years at the time of enrollment
Exclusion Criteria:
* Diagnosed with an immunodeficiency disorder, including HIV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01141959
Study Brief:
Protocol Section:
NCT01141959